CUE icon

Cue Biopharma

49 hedge funds and large institutions have $10.4M invested in Cue Biopharma in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$20K
Puts
$6K
Net Calls
Net Calls Change

Top Buyers

1 +$237K
2 +$69.4K
3 +$57K
4
Renaissance Technologies
Renaissance Technologies
New York
+$33.7K
5
Squarepoint
Squarepoint
New York
+$13.8K

Top Sellers

1 -$436K
2 -$110K
3 -$75.5K
4
Jane Street
Jane Street
New York
-$69.5K
5
HF
HRT Financial
New York
-$53K